Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Liposomes
Reexamination Certificate
2004-05-14
2009-10-13
Schnizer, Richard (Department: 1635)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Liposomes
C536S024500, C435S458000
Reexamination Certificate
active
07601367
ABSTRACT:
Described is a deliverable composition with low toxicity comprising an amphipathic compound, a polycation, and a siRNA. The composition may be used in the process of delivering a siRNA to an animal cell or more particularly, a mammal cell.
REFERENCES:
patent: 5744335 (1998-04-01), Wolff et al.
patent: 6180784 (2001-01-01), Wolff et al.
patent: 6291423 (2001-09-01), Bischoff et al.
patent: 7101995 (2006-09-01), Lewis et al.
patent: 2003/0125281 (2003-07-01), Lewis et al.
patent: 2003/0143204 (2003-07-01), Lewis et al.
patent: 2004/0019008 (2004-01-01), Lewis et al.
Oku et al. (Nov. 2001) Adv. Drug Deliv. Rev. 52:209-218.
Bernstein et al., “Role for a bidentate ribonuclease in the initiation step of RNA interference,” Nature; Jan. 2001, vol. 409, pp. 363-366.
Caplen et al., “dsRNA-mediated gene silencing in cultured drosophila cells: a tissue culture model for the analysis of RNA interference,” Gene; 2000, vol. 252, pp. 95-105.
Caplen et al., “Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems,” PNAS; 2001, vol. 98, No. 17.
Catalanotto et al., “Gene silencing in worms and fungi,” Nature; Mar. 2000, vol. 404, p. 245.
Clemens et al., “The double-stranded RNA-dependent protein kinase PKR: structure and function,” Journal of Interferon and Cytokine Research; 1997, vol. 17, pp. 503-524.
Elbashir et al., “Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells,” Nature; May 2001, vol. 41, pp. 494-498.
Elbashir et al., “RNA interference is mediated by 21- and 22-nucleotide RNAs,” Genes and Development; 2001, vol. 15, pp. 188-200.
Fagard et al., “AG01, QDE-2, and RDE-1 are related proteins required for post-transcriptional gene silencing in plants, quelling in fungi, and RNA interference in animals,” PNAS; Oct. 2000, vol. 97, No. 21, pp. 11650-11654.
Gao et al., “A novel cationic liposome reagent for efficient transfection of mammalian cells,” Biochemical and Biophysical Research Communications; Aug. 1991, vol. 179, No. 1, pp. 280-285.
Hamilton et al., “A species of small antisense RNA in posttranscriptional gene silencing in plants,” Science; Oct. 1999, vol. 286, pp. 950-952.
Hammond et al., “An RNA-directed nuclease mediates post-transcriptional gene silencing in drosophila cells,” Nature; Mar. 2000, vol. 404, pp. 293-296.
Hammond et al., “Post-transcriptional gene silencing by double-stranded RNA,” Nature; Feb. 2001, vol. 2, pp. 110-119.
Ketting et al., “mut-7 of C. elegans, required for transposon silencing and RNA interference, is a homolog of Werner syndrome helicase and RnaseD,” Cell; Oct. 1999, vol. 99, pp. 133-141.
Leventis et al., “Interactions of mammalian cells with lipid dispersions containing novel metabolizable cationic amphiphiles,” Biochimica et Biophysica Acta.; 1990, vol. 1023, pp. 124-132.
Manche et al., “Interactions between double-stranded RNA regulators and the protein kinase DAI,” Molecular and Cellular Biology; Nov. 1992, vol. 12, No. 11, pp. 5238-5248.
Minks et al., “Structural requirements of Double-Stranded RNA for the activation of 2′, 5′-oligo(A) polymerase and protein kinase of interferon-treated HeLa Cells,” The Journal of Biological Chemistry; Oct. 1979, vol. 254, No. 30, pp. 10180-10183.
Parrish et al., “Functional anatomy of a dsRNA trigger: differential requirement for the two trigger strands in RNA interference,” Molecular Cell; Nov. 2000, vol. 6, pp. 1077-1087.
Player et al., “The 2-5 system: Modulation of Viral and cellular processes through acceleration of RNA degradation,” Pharmacol. Ther.; 1998, vol. 78, No. 2, pp. 55-113.
Reidhaar-Olson et al., “The impact of genomics tools on target discovery,” Current Drug Discovery; Apr. 2001.
Sharp “RNAi and double-strand RNA,” Genes and Development; 1999, vol. 13, pp. 139-141.
Sharp et al., “RNA-Interference-2001,” Genes and Development; 2001, vol. 15, pp. 485-490.
Stark et al., “How cells respond to interferons,” Annu. Rev. Biochem.; 1998, vol. 67, pp. 227-264.
Summerton et al., “Morpholino and phosphorothioate antisense oligomers compared in cell-free and in-cell systems,” Antisense and Nucleic Acid Drug Development; 1997, vol. 7, pp. 63-70.
Svoboda et al., “Selective reduction of dormant maternal mRNAs in mouse oocytes by RNA interference,” Development; 2000, vol. 127, pp. 4147-4156.
Tabara et al., “The rde-1 gene, RNA interference, and transposon silencing in C. elegans,” Cell; Oct. 1999, vol. 99, pp. 123-132.
Tuschl et al., “Targeted mRNA degradation by double-stranded RNA in vitro,” Genes and Development; 1999; vol. 13, pp. 3191-3197.
Wianny et al., “Specific interference with gene function by double-stranded RNA in early mouse development,” Nature Cell Biology; Feb. 2000, vol. 2, pp. 70-75.
Yang et al., “Evidence that processed small dsRNAs may mediate sequence-specific mRNA degradation during in drosophilia embryos,” Current Biology; 2000, vol. 10, pp. 1191-1200.
Zamore et al., “RNAi: Double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals,” Cell; Mar. 2000, vol. 101, pp. 25-33.
Goula D et al. “Size, diffusubility and transfection performance of linear PEI/DNA complexes in the mouse central nervous system.” Gene Ther 1998 vol. 5 No. 5 pp. 712-717.
Morcos PA “Achieving efficient delivery of morpholino oligos in cultured cells.” Genesis 2001 vol. 30 p. 94-102.
Hagstrom James E.
Herweijer Hans
Higgs Lori
Lewis David L.
Loomis Aaron G.
Johnson Mark K
Mirus Bio LLC
Schnizer Richard
LandOfFree
Compositions and processes using siRNA, amphipathic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and processes using siRNA, amphipathic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and processes using siRNA, amphipathic... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4101404